Automation strategy in emerging markets: the independence imperative

The Emerging Market Challenge

Automation investment in emerging market laboratories faces a unique set of challenges that compound the risks present in any procurement decision. Vendor concentration is higher, independent advisory capacity is lower, and the information asymmetry between buyer and seller is more pronounced.

The result is a pattern of automation investments that are shaped more by vendor capability and relationship than by the laboratory's actual operational requirements. Equipment is over-specified for current volumes, under-utilized relative to capacity, and locked into service agreements that constrain future flexibility.

Why Independence Matters

Independent automation advisory separates the assessment of need from the recommendation of solution. It ensures that the automation strategy is designed around the laboratory's operational reality, growth trajectory, and financial constraints rather than around a vendor's product portfolio.

This independence is not about being anti-vendor. It is about ensuring that the buyer's interest is protected in a transaction where the information asymmetry inherently favors the seller. The vendor knows their product intimately. The buyer needs an independent party who knows the laboratory's operations equally well.

LTS Global's automation advisory practice operates on a strict vendor-neutral basis. We do not represent, resell, or receive compensation from any equipment manufacturer. Our recommendations are grounded in operational analysis, financial modeling, and the client's strategic objectives.

A Structured Approach

The LTS automation advisory methodology begins with operational assessment: understanding current volumes, growth projections, workflow requirements, and integration constraints. Only after this assessment is complete do we evaluate technology options.

This sequence matters. When technology evaluation precedes operational assessment, the automation strategy is shaped by what is available rather than what is needed. The result is procurement decisions that serve the vendor's pipeline rather than the laboratory's performance.